Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
MBX 4291, dual GLP-1/GIP co-agonist prodrug designed for potential once-monthly dosing and improved tolerability in obesity Recent Highlights: In June 2026, MBX Biosciences announced data that demonstrated sustained benefit of its once-weekly Canvuparatide as a potential PTH replacement therapy in chronic hypoparathyroidism
Alpha-Lipoic Acid Benefits As long as you're healthy, your body can produce all the ALA it needs
Optimization also involves finding your ceiling, the concentration above which results plateau or decline
Anderson M, Goldman RH
US$ 23.32
US$ 29.91
US$ 29.38
US$ 22.04
US$ 20.10
US$ 29.31
